DCM
LAB icon

Driehaus Capital Management’s Standard BioTools LAB Stock Holding History

Driehaus Capital Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-236,479
Closed -$456K – 427
2024
Q3 		$456K Hold
236,479
– – ﹤0.01% 348
2024
Q2 		$419K Hold
236,479
– – ﹤0.01% 340
2024
Q1 		$641K Buy
+236,479
New +$571K 0.01% 335
2019
Q4 		– Sell
-1,674,033
Closed -$7.75M – 537
2019
Q3 		$7.75M Sell
1,674,033
-464,921
-22% -$3.66M 0.25% 107
2019
Q2 		$26.4M Sell
2,138,954
-383,989
-15% -$4.89M 0.83% 23
2019
Q1 		$33.5M Buy
2,522,943
+211,831
+9% +$2.23M 1.26% 10
2018
Q4 		$19.9M Buy
+2,311,112
New +$18M 0.85% 22
2014
Q4 		– Sell
-91,036
Closed -$2.23M – 544
2014
Q3 		$2.23M Buy
91,036
+26,885
+42% +$756K 0.09% 300
2014
Q2 		$1.89M Sell
64,151
-119,691
-65% -$3.84M 0.06% 359
2014
Q1 		$8.1M Buy
183,842
+96,556
+111% +$4.25M 0.25% 100
2013
Q4 		$3.35M Buy
+87,286
New +$2.57M 0.12% 225

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Driehaus Capital Management's LAB Position: Q4 2024 in Review

Driehaus Capital Management sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 236,479 shares — an estimated $456K sold.

Driehaus Capital Management first reported a position in LAB in Q4 2013 and held it in 11 quarters. The position peaked at $33.5M in Q1 2019. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

  • Driehaus Capital Management reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 236,479 Standard BioTools shares in Q4 2024, an estimated $456K.
  • Driehaus Capital Management first reported a position in Standard BioTools in Q4 2013 and held it in 11 quarters.
  • Driehaus Capital Management's Standard BioTools position peaked at $33.5M in Q1 2019.
  • 142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.